Biologically active oxidized lipids (phytoprostanes) in the plant diet and parenteral lipid nutrition

Free Radical Research

Volumn 41, Issue 1, 2007, Pages 25-37

  Karg, Kathrin ^a   Dirsch, Verena M ^b   Vollmar, Angelika M ^b   Cracowski, Jean Luc ^c   Laporte, François ^c   Mueller, Martin J ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Department of Pharmacy ^*  (Germany)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Intralipid; Isoprostanes; Lipid peroxidation; Olive oil; Phytoprostanes; Soybean oil

Indexed keywords

INTRALIPID; LINOLEIC ACID; LIPID; OLIVE OIL; PHYTOPROSTANE; PROSTAGLANDIN A1; PROSTAGLANDIN B; PROSTAGLANDIN E1; PROSTAGLANDIN F; PROSTAGLANDIN J2; SOYBEAN OIL; VEGETABLE OIL;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL FUNCTION; CHEMICAL STRUCTURE; CONTROLLED STUDY; FAT INTAKE; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOCOMPETENT CELL; LIPID ABSORPTION; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; MASS SPECTROMETRY; NONHUMAN; NORMAL HUMAN; PARENTERAL NUTRITION; PLANT NUTRITION; PLANT TISSUE; STRUCTURE ANALYSIS; URINARY EXCRETION;

ADOLESCENT; ADULT; ANIMALS; APOPTOSIS; CYCLOPENTANES; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, UNSATURATED; HUMANS; JURKAT CELLS; MALE; MASS SPECTROMETRY; MICE; NITRIC OXIDE; PARENTERAL NUTRITION; PLANT OILS;

GLYCINE MAX;

EID: 33845430716     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760600939734     Document Type: Article

References (47)

1. Rosell, MS and Lloyd-Wright, Z and Appleby, PN and Sanders, TA and Allen, NE and Key, TJ. (2005) Long-chain n-3 polyunsaturated fatty acids in plasma in British meat-eating, vegetarian, and vegan men Am J Clin Nutr, 82, pp. 327-334.
2. Thoma, I and Krischke, M and Loeffler, C and Mueller, MJ. (2004) The isoprostanoid pathway in plants Chem Phys Lipids, 128, pp. 135-148.
3. Montuschi, P and Barnes, PJ and Roberts, LJ, 2nd. (2004) Isoprostanes: Markers and mediators of oxidative stress Faseb J, 18, pp. 1791-1800.
4. 1) in plants. Plant Physiol 124, pp. 1293-1303.
5. Thoma, I and Loeffler, C and Sinha, AK and Gupta, M and Steffan, B and Krischke, M and Roitsch, T and Mueller, MJ. (2003) Cyclopentenone isoprostanes induced by reactive oxygen species trigger defense gene activation and phytoalexin accumulation in plants Plant J, 34, pp. 363-375.
6. Loeffler, C and Berger, S and Guy, A and Durand, T and Bringmann, G and Dreyer, M and von Rad, U and Durner, J and Mueller, MJ. (2005) B1-phytoprostanes trigger plant defense and detoxification responses Plant Physiol 137, pp. 328-340.
7. Iqbal, M and Evans, P and Lledo, A and Verdaguer, X and Pericas, MA and Riera, A and Loeffler, C and Sinha, AK and Mueller, MJ. (2005) Total synthesis and biological activity of 13,14-dehydro-12-oxo-phytodienoic acids (deoxy-J1-phytoprostanes) Chembiochem, 6, pp. 276-280.
8. Traidl-Hoffmann, C and Mariani, V and Hochrein, H and Karg, K and Wagner, H and Ring, J and Mueller, MJ and Jakob, T and Behrendt, H. (2005) Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization J Exp Med, 201, pp. 627-636.
9. Djousse, L and Arnett, DK and Carr, JJ and Eckfeldt, JH and Hopkins, PN and Province, MA and Ellison, RC. (2005) Dietary linolenic acid is inversely associated with calcified atherosclerotic plaque in the coronary arteries: The National Heart, Lung, and Blood Institute Family Heart Study Circulation, 111, pp. 2921-2926.
10. 1 from α-linolenic acid in plants J Biol Chem, 273, pp. 32650-32655.
11. 1) from α-linolenic acid in plants Free Radic Biol Med, 28, pp. 720-726.
12. 1 pathway Phytochemistry, 62, pp. 351-358.
13. Dirsch, VM and Stuppner, H and Vollmar, AM. (2001) Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2 Cancer Res, 61, pp. 5817-5823.
14. Dirsch, VM and Vollmar, AM. (2001) Ajoene, a natural product with non-steroidal anti-inflammatory drug (NSAID)-like properties? Biochem Pharmacol, 61, pp. 587-593.
15. Green, LC and Wagner, DA and Glogowski, J and Skipper, PL and Wishnok, JS and Tannenbaum, SR. (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids Anal Biochem, 126, pp. 131-138.
16. Dirsch, VM and Kiemer, AK and Wagner, H and Vollmar, AM. (1997) The triterpenoid quinonemethide pristimerin inhibits induction of inducible nitric oxide synthase in murine macrophages Eur J Pharmacol, 336, pp. 211-217.
17. Nicoletti, I and Migliorati, G and Pagliacci, MC and Grignani, F and Riccardi, C. (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry J Immunol Methods, 139, pp. 271-279.
18. Martinez-Force, E and Ruiz-Lopez, N and Garces, R. (2004) The determination of the asymmetrical stereochemical distribution of fatty acids in triacylglycerols Anal Biochem, 334, pp. 175-182.
19. Straus, DS and Glass, CK. (2001) Cyclopentenone prostaglandins: New insights on biological activities and cellular targets Med Res Rev, 21, pp. 185-210.
20. 2 inhibits multiple steps in the NF-ΚB signaling pathway Proc Natl Acad Sci USA, 97, pp. 4844-4849.
21. Musiek, ES and Gao, L and Milne, GL and Han, W and Everhart, MB and Wang, D and Backlund, MG and Dubois, RN and Zanoni, G and Vidari, G and Blackwell, TS and Morrow, JD. (2005) Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages J Biol Chem, 280, pp. 35562-35570.
22. Xie, QW and Kashiwabara, Y and Nathan, C. (1994) Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase J Biol Chem, 269, pp. 4705-4708.
23. 12,14-prostaglandin J2: The endogenous electrophile that induces neuronal apoptosis Proc Natl Acad Sci USA, 99, pp. 7367-7372.
24. Vosseler, CA and Erl, W and Weber, PC. (2003) Structural requirements of cyclopentenone prostaglandins to induce endothelial cell apoptosis Biochem Biophys Res Commun, 307, pp. 322-326.
25. Zernecke, A and Erl, W and Fraemohs, L and Lietz, M and Weber, C. (2003) Suppression of endothelial adhesion molecule up-regulation with cyclopentenone prostaglandins is dissociated from IkappaB-alpha kinase inhibition and cell death induction Faseb J, 17, pp. 1099-1101.
26. Bygdeman, M. (2003) Pharmacokinetics of prostaglandins Best Pract Res Clin Obstet Gynaecol, 17, pp. 707-716.
27. 2 Prostaglandins, 65, pp. 21-31.
28. 2 metabolite generated during inflammatory processes J Biol Chem, 277, pp. 10459-10466.
29. Polet, H and Levine, L. (1975) Metabolism of prostaglandins E, A, and C in serum J Biol Chem, 250, pp. 351-357.
30. Richelle, M and Turini, ME and Guidoux, R and Tavazzi, I and Metairon, S and Fay, LB. (1999) Urinary isoprostane excretion is not confounded by the lipid content of the diet FEBS Lett, 459, pp. 259-262.
31. 2-isoprostane levels Free Radic Biol Med, 28, pp. 806-814.
32. 2-isoprostanes as an index of lipid peroxidation does not appear to be confounded by diet Free Radic Res, 33, pp. 115-127.
33. 2-isoprostanes) are formed in situ on phospholipids Proc Natl Acad Sci USA, 89, pp. 10721-10725.
34. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism Proc Natl Acad Sci USA, 87, pp. 9383-9387.
35. 2t-isoprostane: A bioactive prostanoid metabolite Am J Physiol Regulatory Integrative Comp Physiol, 281, pp. R391-R400.
36. 2α in humans J Biol Chem, 271, pp. 20617-20620.
37. 2α) by a stable isotope dilution mass spectrometric assay Anal Biochem, 269, pp. 326-331.
38. Morrow, JD and Minton, TA and Mukundan, CR and Campbell, MD and Zackert, WE and Daniel, VC and Badr, KF and Blair, IA and Roberts, LJ. (1994) Free radical-induced generation of iso-prostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes J Biol Chem, 269, pp. 4317-4326.
39. Chen, Y and Morrow, JD and Jackson Roberts, L, II. (1999) Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway J Biol Chem, 274, pp. 10863-10868.
40. Waitzberg, DL and Lotierzo, PH and Logullo, AF and Torrinhas, RS and Pereira, CC and Meier, R. (2002) Parenteral lipid emulsions and phagocytic systems Br J Nutr, 87(Suppl 1), pp. S49-S57.
41. Reimund, JM and Scheer, O and Muller, CD and Pinna, G and Duclos, B and Baumann, R. (2004) In vitro modulation of inflammatory cytokine production by three lipid emulsions with different fatty acid compositions Clin Nutr, 23, pp. 1324-1332.
42. Bluml, S and Kirchberger, S and Bochkov, VN and Kronke, G and Stuhlmeier, K and Majdic, O and Zlabinger, GJ and Knapp, W and Binder, BR and Stockl, J and Leitinger, N. (2005) Oxidized phospholipids negatively regulate dendritic cell maturation induced by TLRs and CD40 J Immunol, 175, pp. 501-508.
43. Bochkov, VN and Leitinger, N. (2003) Anti-inflammatory properties of lipid oxidation products J Mol Med, 81, pp. 613-626.
44. Leitinger, N. (2003) Oxidized phospholipids as modulators of inflammation in atherosclerosis Curr Opin Lipidol, 14, pp. 421-430.
45. Berliner, JA and Watson, AD. (2005) A role for oxidized phospholipids in atherosclerosis N Engl J Med, 353, pp. 9-11.
46. Rokach, J and Khanapure, SP and Hwang, S-W and Adiyaman, M and Lawson, JA and FitzGerald, GA. (1997) Nomenclature of Isoprostanes: A proposal Prostaglandins, 54, pp. 853-873.
47. Taber, DF and Morrow, JD and Roberts, JL, II. (1997) A nomenclature system for isoprostanes Prostaglandins, 53, pp. 63-67.